Zobrazeno 1 - 10 of 83 pro vyhledávání: '"Laurent M, Haegeli"'
1
Das «Mickey-Mouse-Herz»
Autor: Judith Meyer, Laurent M. Haegeli, Miriam Brinkert
Publikováno v: Praxis. 111:822-825
Zusammenfassung. Das sogenannte «Mickey-Mouse-Herz» beschreibt Patientinnen und Patienten mit HFpEF, einer massiven biatrialen Dilatation und Anulusdilatation, Vorhofflimmern und schweren AV-Klappeninsuffizienzen. Typischerweise betrifft die Erkran
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ffbc9acf3034fbdb57473af57e0ce907
https://doi.org/10.1024/1661-8157/a003936
Zobrazit plný text záznamu
2
Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms
Autor: Renate B. Schnabel, Isabelle C. Van Gelder, Lukasz Szumowski, Harry J.G.M. Crijns, Günter Breithardt, Sakis Themistoclakis, Karl Wegscheider, Stephan Willems, G. André Ng, Axel Brandes, Laurent M. Haegeli, Hein Heidbuchel, Anna Suling, Panos E. Vardas, Nele Gessler, Katrin Borof, A. John Camm, Paulus Kirchhof, Andreas Goette, Lars Eckardt, Josef Kautzner
Publikováno v: European heart journal
Willems, S, Borof, K, Brandes, A, Breithardt, G, Camm, A J, Crijns, H J G M, Eckardt, L, Gessler, N, Goette, A, Haegeli, L M, Heidbuchel, H, Kautzner, J, Ng, G A, Schnabel, R B, Suling, A, Szumowski, L, Themistoclakis, S, Vardas, P, van Gelder, I C, Wegscheider, K & Kirchhof, P 2022, ' Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms : the EAST-AFNET 4 trial ', European Heart Journal, vol. 43, no. 12, pp. 1219-1230 . https://doi.org/10.1093/eurheartj/ehab593
European Heart Journal, 43(12), 1219-1230. Oxford University Press
Aims Clinical practice guidelines restrict rhythm control therapy to patients with symptomatic atrial fibrillation (AF). The EAST-AFNET 4 trial demonstrated that early, systematic rhythm control improves clinical outcomes compared to symptom-directed
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a94733b570366b41d2a043da473e1b1e
https://doi.org/10.1093/eurheartj/ehab593
Zobrazit plný text záznamu
3
Akademický článek
Low QRS voltage and atrial fibrillation precluding implantation of a subcutaneous implantable cardioverterdefibrillator in a patient with arrhythmogenic cardiomyopathy
Autor: Peter C. Kahr, Jan Steffel, Alexander Breitenstein, Thomas Wolber, Laurent M. Haegeli, Deniz Akdis, Firat Duru, Corinna Brunckhorst, Ardan M. Saguner
Publikováno v: Cardiogenetics, Vol 7, Iss 1 (2017)
Arrhythmogenic cardiomyopathy (AC) is a rare mostly hereditary disease, in which fibro-fatty tissue replaces cardiomyocytes. Typically, the first alterations of the disease can be encountered in the epicardium of the right ventricle in adolescent pat
Externí odkaz: https://doaj.org/article/5a146008a7c74a3dbc1f4b8c731e2936
Zobrazit plný text záznamu
4
Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure
Autor: Karl Wegscheider, Christina Magnussen, Paulus Kirchhof, Anna Suling, Ann-Kathrin Ozga, Isabelle C. Van Gelder, Harry J.G.M. Crijns, Andreas Goette, Günter Breithardt, Karl-Heinz Kuck, Michele Massimo Gulizia, Axel Brandes, Lukasz Szumowski, Andreas Rillig, Arif Elvan, A. John Camm, Hein Heidbuchel, Andre Ng, Laurent M. Haegeli, Lars Eckardt
Publikováno v: Rillig, A, Magnussen, C, Ozga, A-K, Suling, A, Brandes, A, Breithardt, G, Camm, A J, Crijns, H J G M, Eckardt, L, Elvan, A, Goette, A, Gulizia, M, Haegeli, L, Heidbuchel, H, Kuck, K-H, Ng, A, Szumowski, L, van Gelder, I, Wegscheider, K & Kirchhof, P 2021, ' Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure ', Circulation, vol. 144, no. 11, pp. 845-858 . https://doi.org/10.1161/CIRCULATIONAHA.121.056323
Circulation, 144(11), 845-858. LIPPINCOTT WILLIAMS & WILKINS
Circulation
Supplemental Digital Content is available in the text.
Background: Even on optimal therapy, many patients with heart failure and atrial fibrillation experience cardiovascular complications. Additional treatments are needed to reduce these events
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04360aeefd4484cae7caae1bbfe1ce36
https://doi.org/10.1161/circulationaha.121.056323
Zobrazit plný text záznamu
7
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation
Autor: Paulus, Kirchhof, A John, Camm, Andreas, Goette, Axel, Brandes, Lars, Eckardt, Arif, Elvan, Thomas, Fetsch, Isabelle C, van Gelder, Doreen, Haase, Laurent M, Haegeli, Frank, Hamann, Hein, Heidbüchel, Gerhard, Hindricks, Josef, Kautzner, Karl-Heinz, Kuck, Lluis, Mont, G Andre, Ng, Jerzy, Rekosz, Norbert, Schoen, Ulrich, Schotten, Anna, Suling, Jens, Taggeselle, Sakis, Themistoclakis, Eik, Vettorazzi, Panos, Vardas, Karl, Wegscheider, Stephan, Willems, Harry J G M, Crijns, Günter, Breithardt, Anna-Maria, Wnuk-Wojnar
Publikováno v: Kirchhof, P, Camm, A J, Goette, A, Brandes, A, Eckardt, L, Elvan, A, Fetsch, T, van Gelder, I C, Haase, D, Haegeli, L M, Hamann, F, Heidüchel, H, Hindricks, G, Kautzner, J, Kuck, K-H, Mont, L, Ng, G A, Rekosz, J, Schoen, N, Schotten, U, Suling, A, Taggeselle, J, Themistoclakis, S, Vettorazzi, E, Vardas, P, Wegscheider, K, Willems, S, Crijns, H J G M, Breithardt, G & EAST-AFNET 4 Trial Investigators 2020, ' Early Rhythm-Control Therapy in Patients with Atrial Fibrillation ', The New England Journal of Medicine, vol. 383, no. 14, pp. 1305-1316 . https://doi.org/10.1056/NEJMoa2019422
New England Journal of Medicine, 383(14), 1305-1316. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine, 383(14), 1305-1316. MASSACHUSETTS MEDICAL SOCIETY
The New England journal of medicine
BackgroundDespite improvements in the management of atrial fibrillation, patients with this condition remain at increased risk for cardiovascular complications. It is unclear whether early rhythm-control therapy can reduce this risk. MethodsIn this i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ad82057dfe785d9401344301f38a83
https://doi.org/10.1056/nejmoa2019422
Zobrazit plný text záznamu
8
High incidence of inappropriate alarms in patients with wearable cardioverter-defibrillators: findings from the swiss WCD registry
Autor: Laurent M. Haegeli, Tobias Reichlin, Urs Eriksson, Andreas Mueller, André Linka, Jan Steffel, Peter Ammann, Sven Reek, Firat Duru, A.M Saguner, Richard Kobza, Boldizsar Kovacs, Swiss Wcd Registry, Kurt Mayer, Christian Sticherling, Haran Burri
Publikováno v: European Heart Journal. 42
Introduction The wearable cardioverter defibrillator (WCD) uses surface electrodes built into the vest to detect underlying arrhythmia before initiating a treatment sequence. However, it is also prone to inappropriate detection due to artefacts. Purp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2657719937a0cb47ca0a8d3d26d7db04
https://doi.org/10.1093/eurheartj/ehab724.0668
Zobrazit plný text záznamu
9
Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial
Autor: Andreas Goette, Lars Eckardt, Hein Heidbuchel, Günter Breithardt, Anna Suling, Lukasz Szumowski, Laurent M. Haegeli, Isabelle C. Van Gelder, Karl-Heinz Kuck, A. John Camm, Stephan Willems, Paulus Kirchhof, Sakis Themistoclakis, Panos E. Vardas, Arif Elvan, Axel Brandes, Harry J.G.M. Crijns, Karl Wegscheider, Luis Mont, A Andre Ng, Andreas Metzner, Josef Kautzner
Publikováno v: Europace
EP Europace, 24(4), 552-564. Oxford University Press
Europace, 24(4). Oxford University Press
Metzner, A, Suling, A, Brandes, A, Breithardt, G, Camm, A J, Crijns, H J G M, Eckardt, L, Elvan, A, Goette, A, Haegeli, L M, Heidbuchel, H, Kautzner, J, Kuck, K-H, Mont, L, Ng, A A, Szumowski, L, Themistoclakis, S, van Gelder, I C, Vardas, P, Wegscheider, K, Willems, S & Kirchhof, P 2022, ' Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy : a detailed analysis of treatment patterns in the EAST-AFNET 4 trial ', Europace, vol. 24, no. 4, pp. 552-564 . https://doi.org/10.1093/europace/euab200
EP Europace
Aims Treatment patterns were compared between randomized groups in EAST-AFNET 4 to assess whether differences in anticoagulation, therapy of concomitant diseases, or intensity of care can explain the clinical benefit achieved with early rhythm contro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49ca539d7cd7e69390ab02cf5390c12a
https://pubmed.ncbi.nlm.nih.gov/34897422
Zobrazit plný text záznamu
10
A novel score in the prediction of rhythm outcome after ablation of atrial fibrillation: The SUCCESS score
Autor: Fabian Nicolas Jud, Laurent M. Haegeli, Slayman Obeid, Firat Duru
Publikováno v: Anatolian Journal of Cardiology
Objective: The aim of the present study was to assess the predictive value of the CHADS2, CHA2DS2-VASc, R2CHADS2, and APPLE scores for rhythm outcome in patients with atrial fibrillation (AF) after catheter ablation. Methods: The cohort of the presen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f71ecd9a8d5c5795875902326d1dda24
http://europepmc.org/articles/PMC6457407
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje